Abstract
Prior to initiating routine fetal cord serum (FCS) supplementation in our in vitro laboratory, the incidence of HIV in 306 random fetal cord samples obtained at the Labor and Delivery Unit of the Johns Hopkins Hospital from July 1985 to January 1988 was determined from a crosssectional patient sample. Of 306 samples, 3 (0.98%) were positive for HIV, and confirmed by Western blot analysis, enzyme immunoassay (ELISA), a prevalence significantly higher than a national sample (0.012%). The use of FCS in this setting was determined to be an unacceptable risk to patients undergoing in vitro fertilization. The 90-day quarantine period for verification of HIV seronegativity applied to semen donors may not be applicable to FCS sampling. Patient risk may also increase with pooling of FCS samples prior to HIV testing.
References
Feichtinger W, Kemeter P, Menezo Y: The use of synthetic culture medium and patient serum for human in vitro fertilization and embryo replacement. J Vitro Fert Embryo Transfer 1986;3:87–92
Ogawa T, Marrs RP: The effect of protein supplementation on single-cell mouse embryos in vitro. Fertil Steril 1987; 47:156–161
Benadiva CA, Kuczynski-Brown B, Maguire TG, Mastroianni L Jr, Flickinger GL: Bovine serum albumin (BSA) can replace patient serum as a protein source in an in vitro fertilization (IVF) program. J Vitro Fert Embryo Transfer 1989;6:164–167
Groopman JE, Chen FW, Hope JA, et al.: Serological characterization of HIV infection in AIDS and related disorders. J Infect Dis 1986;153:736–742
Sarngadharan MG, Popovic M, Bruch LO, Schupbach J, Gallo RC: Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS. Science 1984;224:506–508
Tsang VCW, Peralta JM, Simons AR: Enzyme-linked immunoglectrotransfer blot techniques (EITB) for studying the specificities of antigens and antibodies separated by gel electrophoresis. Methods Enzymol 1983;92:377–391
United States Morbidity and Mortality Weekly Report 36, 1987
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Damewood, M.D., Hesla, J.S., Schlaff, W.D. et al. The incidence of human immunodeficiency virus (HIV) in fetal cord samples utilized as serum supplements for in vitro fertilization. J Assist Reprod Genet 7, 365–366 (1990). https://doi.org/10.1007/BF01130593
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01130593